Longevity
Metformin's Second Act: From Diabetes Pill to Longevity Candidate
A cheap, decades-old drug is being reframed as a possible geroprotective adjuvant. The science is intriguing — and still unfinished.
cancer prevention
Metabolic Health
Sitting Still: How Sedentary Time Became a Measurable Cancer Risk
A new wave of population-level research is moving the link between chair-time and cancer from slogan to statistics — and reframing movement as a quiet prevention lever for desk-bound lives.